In light of the FDAs recent decision, we are evaluating our treatment offerings to ensure they align with current regulations and continue to serve our patients best interests
Latest GLP-1 Study 2025: Key Findings Everyone Is Talking About The latest GLP-1 study 2025 (ATTAIN-1) shows that orforglipron led to meaningful weight loss, better metabolic control, and improvements in heart-related markers
the use of polystyrene resins and large volumes of organic solvents generates toxic waste ( [20] )
Methods A total of 147 women with PCOS were randomly assigned into two groups: the combo group ( n = 72) received a combination of metformin, pioglitazone, and ALC (500 mg, 15 mg, and 1500 mg, respectively), twice daily
Preclinical research has investigated BPC-157 for its potential effects on tissue regeneration, inflammatory modulation, and the nitric oxide system
(Daejeon, Republic of Korea)